TransMedics Group Inc. (TMDX)
93.47
-0.71 (-0.75%)
At close: Apr 25, 2025, 3:59 PM
93.50
0.03%
After-hours: Apr 25, 2025, 05:58 PM EDT
TransMedics Revenue Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
|---|---|---|---|---|---|---|---|
| Product Revenue | 65.86M | 71.73M | 61.33M | 88.51M | 11.09M | 42.46M | 33.99M |
| Product Revenue Growth | -8.18% | +16.97% | -30.71% | +698.36% | -73.89% | +24.91% | n/a |
| Service Revenue | 42.9M | 42.57M | 35.52M | n/a | 14.68M | 10M | 7.56M |
| Service Revenue Growth | +0.77% | +19.84% | n/a | n/a | +46.78% | +32.30% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 28, 2019 |
|---|---|---|---|---|
| Other Countries Revenue | 880K | 21.86M | 19.24M | 3.97M |
| Other Countries Revenue Growth | -95.97% | +13.63% | +384.49% | n/a |
| United States Revenue | 7.97M | n/a | n/a | 16.25M |
| United States Revenue Growth | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 28, 2019 | Sep 28, 2019 | Jun 29, 2019 | Mar 30, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 30, 2017 | Sep 30, 2017 | Jul 1, 2017 | Apr 1, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 42.66M | 42.8M | 36.06M | 34.56M | 30.65M | 29.36M | 24.98M | 21.73M | 16.85M | 17.38M | 13.94M | 12M | 10.34M | 9.16M | 6.79M | 6.18M | 5.49M | 5.87M | 6.65M | 6.17M | 6.52M | 6.25M | 4.65M | 4.37M | 2.8M | 2.9M | 2.24M | 1.63M | 1.81M | 2.33M | 2.08M |
| Selling, General, and Administrative Revenue Growth | -0.32% | +18.67% | +4.34% | +12.75% | +4.42% | +17.50% | +15.00% | +28.93% | -3.05% | +24.69% | +16.16% | +16.11% | +12.80% | +35.01% | +9.88% | +12.43% | -6.37% | -11.80% | +7.76% | -5.31% | +4.29% | +34.34% | +6.38% | +56.27% | -3.55% | +29.55% | +37.17% | -9.88% | -22.23% | +11.99% | n/a |
| Research and Development Revenue | 14.27M | 13.86M | 11.38M | 10.76M | 38.34M | 8.29M | 5.87M | 5.76M | 6.81M | 6.71M | 7.53M | 6.31M | 5.16M | 6.29M | 4.53M | 4.55M | 4.16M | 3.9M | 6.22M | 6.26M | 4.94M | 4.79M | 3.88M | 3.49M | 3.27M | 3.43M | 3.46M | 3.4M | 3.4M | 4.19M | 4.08M |
| Research and Development Revenue Growth | +2.94% | +21.78% | +5.75% | -71.94% | +362.48% | +41.22% | +2.00% | -15.45% | +1.40% | -10.88% | +19.32% | +22.29% | -17.98% | +38.90% | -0.35% | +9.46% | +6.46% | -37.30% | -0.59% | +26.79% | +3.18% | +23.31% | +11.36% | +6.54% | -4.69% | -0.92% | +1.85% | 0.00% | -18.86% | +2.86% | n/a |